Patents Assigned to Dovetail Technologies, Inc.
  • Patent number: 6762174
    Abstract: The present invention relates to peptide-like compounds, e.g. aminocarboxylic acid amide derivatives, and to methods of using same to stimulate cells of the immune system, bone marrow and other organs. The present compounds can be used to enhance vaccination, increase synthesis of and enhance function of blood cell components and enhance anti-neoplastic effects of various agents. The compounds of the invention can be used to produce a variety of further pharmacologic effects.
    Type: Grant
    Filed: February 24, 1999
    Date of Patent: July 13, 2004
    Assignee: Dovetail Technologies, Inc.
    Inventor: Floyd E. Taub
  • Patent number: 6498150
    Abstract: The present invention relates to peptide-like compounds, eg aminocarboxylic acid amide derivatives, and to methods of using same to stimulate cells of the immune system, bone marrow and other organs. The present compounds can be used to enhance vaccination, increase synthesis of and enhance function of blood cell components and enhance anti-neoplastic effects of various agents. The compounds of the invention can be used to produce a variety of further pharmacologic effects.
    Type: Grant
    Filed: October 7, 1999
    Date of Patent: December 24, 2002
    Assignee: Dovetail Technologies, Inc.
    Inventors: Floyd Taub, Thomas J. Perun, Christopher K. Murray, Randall J. Daughenbaugh, Daniel Lednicer
  • Patent number: 6451853
    Abstract: The present invention relates to methods of using peptide-like compounds, e.g., aminocarboxylic acid amide derivatives, to bias the immune system toward producing, enhancing, or maintaining a polarized Th1 response, and to methods for treating diseases that improve by creating a Th1 response. The invention also relates to a method of treating diseases associated with elevated soluble TNF alpha levels by administering beta-alethine together with NAC to reduce soluble TNF alpha, and to a pharmaceutical composition comprising same. The present compounds can be used to modulate cytokines including IFN-gamma and IL-10.
    Type: Grant
    Filed: February 24, 1999
    Date of Patent: September 17, 2002
    Assignee: Dovetail Technologies, Inc
    Inventors: Floyd E. Taub, Carol H. Pontzer
  • Patent number: 6414114
    Abstract: The present invention is directed to novel disulfides and thiols that are of up to about eighteen amino acids. One example, is a compound of the formula (1): A—B—C—S—S—D—E—F, wherein: A and F are selected from the group consisting of hydrogen, an amino acid, a dipeptide, a tripeptide, a modified polypeptide up to three amino acids long, and a carbobenzoxy groups, B and E are selected from the group consisting of an amino acid, a dipeptide, a tripeptide, and a modified polypeptide comprising up to and including three amino acids, C and D are selected from the group consisting of a modified polypeptide and a polypeptide comprising up to and including three amino acids, and S is the sulfur atom in the modified polypeptide and the polypeptide in C and D.
    Type: Grant
    Filed: February 24, 1999
    Date of Patent: July 2, 2002
    Assignee: Dovetail Technologies, Inc.
    Inventors: Floyd E. Taub, Christopher K. Murray, Randall J. Daughenbaugh, Daniel Lednicer
  • Patent number: 6166086
    Abstract: The present invention relates to peptide-like compounds, eg aminocarboxylic acid amide derivatives, and to methods of using same in the field of general health care, for example, to improve resistance to stress, improve production of desired characteristics or useful products in animals, to increase weight gain, and to decrease feed efficiency. The invention has applications in the field of animal husbandry. It also relates to administering beta-alethine to improve feed efficiency in an animal, comprising administering to animal an amount of .beta.-alethine sufficient to reduce the amount of food required to increase a unit of weight in the animal.
    Type: Grant
    Filed: February 24, 1999
    Date of Patent: December 26, 2000
    Assignee: Dovetail Technologies, Inc.
    Inventor: Floyd E. Taub
  • Patent number: 6007819
    Abstract: The present invention relates to peptide-like compounds, eg aminocarboxylic acid amide derivatives, and to methods of using same to stimulate cells of the immune system, bone marrow and other organs. The present compounds can be used to enhance vaccination, increase synthesis of and enhance function of blood cell components and enhance anti-neoplastic effects of various agents. The compounds of the invention can be used to produce a variety of further pharmacologic effects.
    Type: Grant
    Filed: October 17, 1996
    Date of Patent: December 28, 1999
    Assignee: Dovetail Technologies, Inc.
    Inventors: Floyd Taub, Thomas J. Perun, Christopher K. Murray, Randall J. Daughenbaugh, Daniel Lednicer